A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Hackensack Meridian Health
Acerta Pharma BV
M.D. Anderson Cancer Center
Gilead Sciences
University of Washington
Mayo Clinic
Dana-Farber Cancer Institute
Roswell Park Cancer Institute
University of Maryland, Baltimore
City of Hope Medical Center
Janssen Pharmaceutical K.K.
University College, London
BeiGene
City of Hope Medical Center
Mayo Clinic
Weill Medical College of Cornell University
University of Nebraska
Eastern Cooperative Oncology Group
TG Therapeutics, Inc.
Abramson Cancer Center at Penn Medicine
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Mayo Clinic
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Eli Lilly and Company
Dana-Farber Cancer Institute
Gilead Sciences
Pharmacyclics LLC.
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
University of Washington
Fred Hutchinson Cancer Center
University of Arizona
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
University of Chicago
Gilead Sciences
Fred Hutchinson Cancer Center
Mayo Clinic
Barbara Ann Karmanos Cancer Institute